IOC 2016 IOC vs Adem Kılıçcı

Mr Adem Kılıçcı is a Turkish Athlete competing in the Men’s 69-75 kg boxing event at the 2012 London Olympic Games.

In 2016, the IOC decided to perform further analyses on certain samples collected during the 2012 Olympic Games. These additional analyses were performed with analytical methods which were not available in 2012.

In May 2016 the International Olympic Committee reported an anti-doping rule violation against the Athlete after his 2012 A and B samples tested positive for the prohibited substance dehydrochlormethyltestosterone (turinabol). After notification the Athlete filed a statement in his defence and he was heard for the IOC Disciplinary Commission.

The Athlete denied the use of prohibited substances, he never tested positive in his career and contended that the presence of a Prohibited Substance in his bodily sample may be a result of a contaminated product unintentionally ingested.

The Disciplinary Commission notes that athletes have long been warned against the use of supplements. As such, the fact that turinabol may have been ingested as part of a supplement is not likely to constitute an element exonerating the Athlete from having been at fault for using a Prohibited Substance.
In this respect, the Disciplinary Commission observes that supplements do not, as a rule, contain turinabol and that accidental contamination of a legitimate supplement by this substance appears to be very unlikely.

With the positive test results the Commission concludes that the Athlete has committed an anti-doping rule violation consistent with intentional use of prohibited substances specifically ingested to deliberately improve performance. The fact that the metabolites of a doping substance, which is a “classical” doping substance, was found, supports this consideration.

The Disciplinary Commission, which has now handled multiple cases arising out of the reanalysis of samples from the 2008 and 2012 Olympic Games, observes that the presence of metabolites of this particular substance has been established in a remarkably high number of cases, which resulted from the re-analysis of the samples collected in Beijing 2008 and London 2012. This constitutes an indication that said substance has been in widespread use by athletes, who were doping at that time.

Therfore the IOC Disciplinary Commission decides on 27 January 2017 that the Athlete, Adem Kılıçcı:

1.) is found to have committed an anti-doping rule violation pursuant to the IOC Anti-Doping Rules applicable to the Games of the XXX Olympiad in London in 2012 (presence, and/or use, of Prohibited Substances or its Metabolites or Markers in an athlete’s bodily specimen),
2.) is disqualified from the event in which he participated upon the occasion of the Olympic Games London 2012, namely the Men’s 69-75 kg boxing event, in which he ranked 5th and for which he was awarded a diploma.
3.) has the diploma obtained in the Men’s 69-75 kg boxing event withdrawn and is ordered to return the same.
4.) The AIBA is requested to modify the results of the above-mentioned event accordingly and to consider any further action within its own competence.
5.) The Turkish Olympic Committee shall ensure full implementation of this decision.
6.) The Turkish Olympic Committee shall notably secure the return to the IOC, as soon as possible, of the diploma awarded in connection with the Men’s 69-75 kg boxing event to the Athlete.
7.) This decision enters into force immediately.

show »
Type:
pdf

Parameters:

Doping classes
S1. Anabolic Agents
Laboratories
Lausanne (SWI)
London (GBR)
Legal
IOC Decisions
Date:
27 January 2017
Arbitrator
Lindberg, Gunilla
Oswald, Denis
Samaranch Salisachs, Juan Antonio
Source
International Olympic Committee (IOC)
Country
Turkey
Language
English
ADRV
Adverse Analytical Finding
Document type
pdf
IF'S
Boxing (AIBA) - International Boxing Association
Laboratories/Analysis
B sample analysis
Reanalysis
Legal Terms
Removal of accreditation for the Olympic Games
Organisations
International Olympic Committee (IOC)
Substances
Dehydrochlormethyltestosterone (4-chloro-17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Various
Disqualified competition results
Supplements
Category
  • (Medical) Science
  • Doping classes
  • Education
  • History
  • Laboratories
  • Legal
  • Statistics
Publication period
Origin
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Document category
  • Document type
  • Health/Medical
  • IF'S
  • Laboratories/Analysis
  • Legal Terms
  • Organisations
  • Substances
  • Various
  • Version